Patient retention or patient engagement have become a main operational challenge in today’s clinical trials. Despite major investments…
Cognivia launches the world’s first real-time behavioral risk intelligence dashboard—Cognivia Signal—empowering clinical teams to see what’s coming before…
New Publication in The Journal of Pain Demonstrates Scalable Method to Improve Measurement of Subjective Endpoints in Clinical Trials Mont-Saint-Guibert,…
As the global obesity drug market accelerates toward an estimated $200 billion valuation, sponsors face more than just…
At the United States Association for the Study of Pain 2025 conference, Cognivia presented compelling new data from…
At the recent 2025 Advanced Technologies & Treatments for Diabetes congress in Amsterdam, Cognivia presented two new scientific posters demonstrating…